Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,905 | 5,996 | 2,757 | 16,980 | 35,260 |
| Marketable Securities | 459 | 1,202 | 756 | 23 | 158 |
| Receivables | 231 | 3,807 | 7,417 | 374 | 501 |
| Inventories | 52 | 117 | N/A | N/A | N/A |
| Other current assets | 3,815 | 861 | 0 | 0 | 8,648 |
| TOTAL | $6,478 | $12,053 | $11,085 | $17,850 | $45,933 |
| Non-Current Assets | |||||
| PPE Net | 169 | 130 | 120 | 261 | 168 |
| Investments And Advances | 0 | 2 | 6 | 828 | 660 |
| Intangibles | 4,513 | 4,934 | 5,356 | 12,040 | 16,202 |
| Other Non-Current Assets | 0 | 0 | 907 | 7,432 | 0 |
| TOTAL | $4,683 | $5,066 | $6,390 | $20,560 | $17,030 |
| Total Assets | $11,161 | $17,119 | $17,475 | $38,411 | $62,963 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,773 | 771 | 301 | 301 | 301 |
| Accounts payable and accrued liabilities | 1,982 | 3,255 | 3,241 | 2,760 | 2,996 |
| Accrued Expenses | 2,200 | 1,107 | 954 | 4,348 | 4,409 |
| Other current liabilities | N/A | 492 | 31 | 244 | 765 |
| TOTAL | $6,058 | $6,679 | $4,566 | $7,830 | $8,701 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | 1,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,822 | 1,040 | 328 | 0 | 0 |
| TOTAL | $0 | $0 | $0 | $38 | $131 |
| Total Liabilities | $6,058 | $6,679 | $4,566 | $7,868 | $8,832 |
| Shareholders' Equity | |||||
| Common Shares | 169,703 | 150,470 | 137,778 | 143,411 | 152,325 |
| Retained earnings | -198,286 | -172,111 | -157,908 | -144,164 | -126,154 |
| Other shareholders' equity | 102 | 2,049 | 3,141 | 2,795 | 5,377 |
| TOTAL | $6,924 | $11,481 | $13,237 | $30,542 | $54,131 |
| Total Liabilities And Equity | $12,983 | $18,160 | $17,802 | $38,411 | $62,963 |